These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8439684)

  • 1. Peritoneal transfer during maximal hyperosmotic ultrafiltration in the rat.
    Grzegorzewska AE; Moore HL; Chen TW; Nolph KD
    ASAIO J; 1993; 39(1):66-70. PubMed ID: 8439684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal transfer of carbon dioxide in the rat.
    Grzegorzewska AE; Moore HL; Chen TW; Nolph KD
    ASAIO J; 1992; 38(4):823-9. PubMed ID: 1450480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal clearances of carbon dioxide in the rat.
    Grzegorzewska AE; Moore HL; Chen TW; Nolph KD
    Adv Perit Dial; 1992; 8():26-9. PubMed ID: 1361802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B does not increase peritoneal fluid removal.
    Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
    Adv Perit Dial; 1998; 14():3-10. PubMed ID: 10649681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal filtration fraction (PFF).
    Grzegorzewska AE
    Adv Perit Dial; 1994; 10():30-2. PubMed ID: 7999851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration and effective peritoneal blood flow during peritoneal dialysis in the rat.
    Grzegorzewska AE; Moore HL; Nolph KD; Chen TW
    Kidney Int; 1991 Apr; 39(4):608-17. PubMed ID: 1904962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
    J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sieving coefficients for small solutes during experimental peritoneal dialysis in rats.
    Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B
    Blood Purif; 1995; 13(6):289-300. PubMed ID: 8821193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of intraperitoneal pressure in peritoneal dialysis and measures to counteract its effect on net ultrafiltration.
    Flessner MF
    Adv Perit Dial; 1999; 15():45-52. PubMed ID: 10682071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
    Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
    Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal fluid kinetics: comparison between polyglucose solution and albumin solution.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():21-7. PubMed ID: 10682066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of glycylglycine peritoneal dialysis solution with neutral pH on peritoneum in rats.
    Wieczorowska-Tobis K; Korybalska K; Polubińska A; Radkowski M; Breborowicz A; Montagne A; Oreopoulos DG
    Adv Perit Dial; 1997; 13():42-6. PubMed ID: 9360649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transport processes--ultrafiltration in peritoneal dialysis].
    Nesić V; Dimitrijević Z; Stojimirović B
    Srp Arh Celok Lek; 1996; 124 Suppl 1():159-62. PubMed ID: 9102889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measuring ionized calcium (Ca2+) transport during intermittent peritoneal dialysis (IPD)].
    Grzegorzewska A; Chalama B; Mariak I; Kupsz J
    Przegl Lek; 1997; 54(5):302-7. PubMed ID: 9380803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of new dialysis solutions on clinical results in patients treated with peritoneal dialysis].
    Haag-Weber M
    Wien Klin Wochenschr; 2005; 117 Suppl 6():89-97. PubMed ID: 16437339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Jimenez C; Del Peso G; Sanchez C; de Alvaro F
    Adv Perit Dial; 1996; 12():49-52. PubMed ID: 8865872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilatation by intraperitoneal addition of nitroprusside is not a model for high peritoneal transport.
    Wang T; Cheng HH; Heimbürger O; Bergström J; Lindholm B
    Adv Perit Dial; 1999; 15():53-9. PubMed ID: 10682072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.